News from BAT Research & Development
To keep up to date with our latest science and innovation follow @BAT_Sci, where we will regularly report on our publications, conference materials, news and multimedia. We look forward to talking with you!
The first comprehensive assessment of the acrylamide content of smokeless tobacco products (STPs) has shown that exposure to acrylamide through STP use is much smaller than —approximately 1% of — exposure from the diet or from cigarette smoking.
Scientists at British American Tobacco have proposed a new scientific framework that could be used to assess the reduced-risk promise of the myriad of innovative nicotine and tobacco products currently being developed.
Our Chief Scientific Officer, Chris Proctor, is in Boston at the Fall National meeting of the American Chemical Society. His talk will cover the ACS policy making, and the importance of scientific integrity to making progress on tobacco harm reduction as part of a full day session hosted by the Chemical Information Division.
As part of our open and transparent approach, we have designed an interactive visitor exhibit to showcase our science. Our exhibit room, R&D Live, puts you in direct conversation with our scientists as they explain the concept of their work.